Formulated for schizophrenia to manage psychiatric symptoms and support behavioral regulation.
Mechanism of Action
Aripiprazole acts as a partial agonist at dopamine D2 and serotonin 5-HT1A receptors and as an antagonist at 5-HT2A receptors. This unique activity stabilizes neurotransmission, providing antipsychotic effects with a lower risk of metabolic side effects.
Information related to Aripiprazole is compiled and periodically reviewed with reference to established medical sources and prescribing guidance. Content is provided for general reference and should be confirmed with a registered healthcare professional before use.
